Your Comments are Important to Us

Welcome to the enhanced iDBL. The site has been enhanced with improved search features and a new look.

Your Comments are Important to Us

Your Comments Disclosure for Potential Conflicts of Interest

Anyone who wants to give comments about Drug Products to the Alberta Health Expert Committee on Drug Evaluation and Therapeutics (ECDET) must complete a Declaration of Conflict of Interest Form. A conflict of interest is when opinions may be affected by family, friendships, or relationships with support groups, or by receiving money or gifts from companies related to the Drug Product.

If the Conflict of Interest form is not completed, or if you do not report conflicts on the form you send in but we find there are conflicts when your form is looked over; your comments will not be sent to the Expert Committee.

Your Contact Information:

To improve the high standards established for this publication, the Alberta Health Expert Committee on Drug Evaluation and Therapeutics would like to offer you an opportunity for input. Should you have any concerns and/or suggestions concerning product listings or criteria for coverage of products available via special authorization, etc. please let us know.

If you are writing in support of a product listing change or a revision to the special authorization criteria for coverage, you must provide evidence in support of your comments from the peer-reviewed scientific literature. If you would like to provide references from the scientific literature as attachments, please e-mail the literature to with your full name in the subject header. Please note that these attachments and your comments will not be considered until a Conflict of Interest form is completed and submitted.

Please note: this is not a mechanism for an appeal for a specific patient.


The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross® who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL (iDBL), and any such changes to the Interactive DBL (iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.